Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study

A Correction to this article was published on 28 September 2019

This article has been updated

Abstract

Background Studies in international literature have shown that Community Pharmacists can make considerable impact in controlling cardiovascular disease risk factors, especially hypertension. In Nigeria, there are no studies on the knowledge of CVD risk factors by Community Pharmacists and their practice of primary prevention. Objective To assess the knowledge of CVD risk factors and practice of primary prevention of CVD amongst Nigerian community pharmacists. Setting Community Pharmacists in Lagos, Nigeria. Methods This cross-sectional study involved 168 Community Pharmacists. Their knowledge of CVD risk factors was assessed with the Heart Disease Fact Questionnaire. Their opportunistic screening practices for CVD risk factors (primary prevention) were also assessed. Main outcome measures Knowledge of CVD risk factors and practice of primary CVD prevention. Results The mean age of the participating pharmacists was 41.7 (± 11.2) years and 87 (51.8%) of them were males. The median number of years of practice was 9.0 (3–15) years. Mean knowledge score was 22.1 (± 3.0) with 154 (91.7%) of the subjects scoring above 70%. An average of 95.5% of the participants correctly identified hypertension, smoking, dyslipidaemia, obesity, physical inactivity and diabetes as CVD risk factors. Eighty-one (48.2%) had good practice of primary CVD prevention. Conclusion: This study shows that Community Pharmacists in Nigeria have very good knowledge level of CVD risk factors and almost 50% of them practised primary prevention of CVD.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

Change history

  • 28 September 2019

    The article Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study

  • 28 September 2019

    The article Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study

References

  1. 1.

    World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva, Switzerland; 2007. Accessed 22 July 2015.

  2. 2.

    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.

    Article  Google Scholar 

  3. 3.

    Bygbjerg IC. Double burden of non-communicable and infectious diseases in developing countries. Science. 2012;337(6101):1499–501.

    CAS  Article  Google Scholar 

  4. 4.

    Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part II. Variation in cardiovascular diseases by specific ethnic groups and geographic regions and preventive strategies. Circulation. 2001;104(23):2855–64.

    CAS  Article  Google Scholar 

  5. 5.

    Steyn K, Sliwa K, Hawken S, Commerford P, Onen C. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa Study. Circulation. 2005;112:3554–61.

    Article  Google Scholar 

  6. 6.

    Adeloye D, Basquill C, Aderemi AV, et al. An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis. J Hypertens. 2015;33(2):230–42.

    CAS  Article  Google Scholar 

  7. 7.

    International Diabetes Federation. 6th ed. 2013. p. 23–6. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/19-atlas-6th-edition.html. Accessed 17 Nov 2018.

  8. 8.

    Ogbera OA, Ekpebegh C. Diabetes mellitus in Nigeria: the past, present and future. World J Diabetes. 2014;5(6):905–11.

    Article  Google Scholar 

  9. 9.

    Odeyemi KA, Osibogun A, Akinsele AO, Sadiq L. The prevalence and predictors of cigarette smoking in secondary students in Nigeria. Niger Postgrad Med J. 2009;16:40–5.

    CAS  PubMed  Google Scholar 

  10. 10.

    Akaralo-Anthony SN, Adebamowo CA. Prevalence and correlates of leisure-time physical activity among Nigerians. BMC Public Health. 2014;14:529.

    Article  Google Scholar 

  11. 11.

    World Health Organization. Global strategy on diet, physical activity & health. 2004. http://www.who.int/nmh/wha/59/dpas/en/. Accessed 17 Nov 2018.

  12. 12.

    Ogundamola OJ, Oladosun OY. Pattern and outcomes of admissions in the medical wards of a tertiary health centre in a rural community of Ekiti State, Nigeria. Ann Afr Med. 2014;13:195–203.

    Article  Google Scholar 

  13. 13.

    Oguanobi NI, Ejim EC, Onwubere BJ, Ike SO, Anisiuba BC, Ikeh VO, Aneke EO. Pattern of cardiovascular disease amongst medical admissions in a regional teaching hospital in South-eastern Nigeria. Niger J Cardiol. 2013;10:77–80.

    Article  Google Scholar 

  14. 14.

    Schwappach D, Boluarte T, Suhrcke M. The economics of primary prevention of cardiovascular disease—a systematic review of economic evaluations. Cost Eff Resour Alloc. 2007;5(1):5.

    Article  Google Scholar 

  15. 15.

    Ferdinand KC, Patterson KP, Taylor C, Fergus IV, Nasser SA. Community-based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012;14:336–43.

    Article  Google Scholar 

  16. 16.

    Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41(11):1770–81.

    Article  Google Scholar 

  17. 17.

    Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health. 2003;25(2):144–53.

    Article  Google Scholar 

  18. 18.

    Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.

    Article  Google Scholar 

  19. 19.

    George J, McNamara GJ, Stewart K. The roles of community pharmacists in cardiovascular disease prevention and management. AMJ. 2011;4(5):266–72.

    CAS  Article  Google Scholar 

  20. 20.

    Santschi VS, Colosimo AL, Chilero A, Burnand B, Paradis G. Pharmacists interventions to improve cardiovascular risk factors in diabetes. a systematic review and meta-analysis. Diabetes Care. 2012;35:2706–17.

    Article  Google Scholar 

  21. 21.

    Araoye MO. Sample size determination. In: Research methodology with statistics for health and social sciences. 1st Ed. Ilorin: Nathadex Publishers; 2004. p. 115–20.

  22. 22.

    Wagner J, Lacey K, Chyun D, Abbot D. Development of a questionnaire to measure heart disease risk knowledge in people with diabetes. The Heart Disease Facts Questionnaire. Patient Educ Couns. 2005;58:82–7.

    Article  Google Scholar 

  23. 23.

    Wagner J, Lacey K, Chyun D, Abbot D. Knowledge of heart disease risks among Spanish speakers with diabetes. The role of interpreters in the medical encounter. Ethn Dis. 2005;15:679–84.

    PubMed  Google Scholar 

  24. 24.

    Akintunde AA, Akintunde TS, Opadijo OG. Knowledge of heart disease risk factors among workers in a Nigerian University. A call for concern. Niger Med J. 2015;56(2):91–5.

    Article  Google Scholar 

  25. 25.

    Joyce A, Berbatis C, Sunderland VB. Analysis of primary prevention services for cardiovascular disease in Australia’s community pharmacies. Aust N Z J Public Health. 2007;31:516–9.

    Article  Google Scholar 

  26. 26.

    Jahangard-Rafsanjani Z, Hakimzadeh N, Sarayani A, Najafi S, Heidari K, Javadi MR, Hadjibabaie M, Gholami K. A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharm Pract. 2017;15(2):919–25.

    Article  Google Scholar 

  27. 27.

    Via-Sosa MA, Toro C, Trave P, March MA. Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study. BMC Public Health. 2014;14:487.

    Article  Google Scholar 

  28. 28.

    Willis A, Rivers P, Gray LJ, Davies M, Khunti K. The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS ONE. 2014;9(4):e91157.

    Article  Google Scholar 

  29. 29.

    Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of cardiovascular opportunistic risk assessment pilot (‘Heart MOT’ service) in community pharmacies. J Public Health. 2010;32(1):110–6.

    CAS  Article  Google Scholar 

  30. 30.

    O’Donovan DO, Byre S, Sahm LJ. Pharmacists use of screening tools to estimate risk of CVD: a review of the literature. Pharmacy. 2014;2:27–39.

    Article  Google Scholar 

  31. 31.

    Rohla M, Haberfeld H, Sinzinger H, et al. Systematic screening for cardiovascular risk in pharmacies. Open Heart. 2016;3:e000497.

    Article  Google Scholar 

  32. 32.

    Taylor J, Krska J, Mackridge A. A community pharmacy-based cardio-vascular screening service: views of service users and the public. Int J Pharm Pract. 2012;20:277–84.

    Article  Google Scholar 

  33. 33.

    Hindi AMK, Schafheutle EI, Jacobs S. Patients and public perspectives of community pharmacies in the UK: a systematic review. Health Expect. 2018;21:409–28.

    Article  Google Scholar 

  34. 34.

    Chiazor EI, Evans M, van Worden H, Oparah AC. A systematic review of community pharmacists’ interventions in reducing major risk factors for cardiovascular disease. J Value Health Reg Issues. 2015;7c:9–21.

    Article  Google Scholar 

  35. 35.

    Jahangard-Rafsanjani Z, Sarayani A, Javadi MR, Hadjibabaie M, Rashidian A, Ahmadvand A, et al. Pharmacists’ attitudes and perceived barriers about community pharmacy-based cardiovascular risk screening services. J Pharm Care. 2014;2(4):142–8.

    Google Scholar 

  36. 36.

    Kotecki JE, Elanjian SI, Torabi MR. Health promotion beliefs and practices amongst pharmacists. J Am Pharm Asso. 2000;40:773–9.

    CAS  Google Scholar 

  37. 37.

    Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30:211–5.

    Article  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Casmir E. Amadi.

Ethics declarations

Conflicts of interest

None.

Additional information

The original version of this article was revised: Due to open choice cancellation.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Amadi, C.E., Lawal, F.O., Mbakwem, A.C. et al. Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study. Int J Clin Pharm 40, 1587–1595 (2018). https://doi.org/10.1007/s11096-018-0744-3

Download citation

Keywords

  • Community Pharmacists
  • CVD
  • Hypertension
  • Primary prevention
  • Nigeria